Use of Recombinant Factor VIIa in Symptomatic Intracerebral Hemorrhage Following Intravenous Thrombolysis

Symptomatic intracerebral hemorrhage (sICH) occurs in up to 7% of stroke patients treated with thrombolytic therapy. There are limited data on the effectiveness of the reversal agents used for intravenous tissue plasminogen activator related intracranial bleeds. We report a patient with sICH followi...

Descripción completa

Detalles Bibliográficos
Autores principales: Yaghi, Shadi, Haggiagi, Aya, Sherzai, Ayesha, Marshall, Randolph S., Agarwal, Sachin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: PAGEPress Publications, Pavia, Italy 2015
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4500881/
https://www.ncbi.nlm.nih.gov/pubmed/26236459
http://dx.doi.org/10.4081/cp.2015.756

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4500881/
https://www.ncbi.nlm.nih.gov/pubmed/26236459
http://dx.doi.org/10.4081/cp.2015.756

Ejemplares similares